SE7504221L - Cellvirusvaccin och forfarande for framstellning av vaccinet. - Google Patents

Cellvirusvaccin och forfarande for framstellning av vaccinet.

Info

Publication number
SE7504221L
SE7504221L SE7504221A SE7504221A SE7504221L SE 7504221 L SE7504221 L SE 7504221L SE 7504221 A SE7504221 A SE 7504221A SE 7504221 A SE7504221 A SE 7504221A SE 7504221 L SE7504221 L SE 7504221L
Authority
SE
Sweden
Prior art keywords
vaccine
manufacturing
methods
cell virus
cmv
Prior art date
Application number
SE7504221A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Inventor
S A Plotkin
Original Assignee
Wistar Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wistar Inst filed Critical Wistar Inst
Publication of SE7504221L publication Critical patent/SE7504221L/

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE7504221A 1974-04-15 1975-04-14 Cellvirusvaccin och forfarande for framstellning av vaccinet. SE7504221L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/460,951 US3959466A (en) 1974-04-15 1974-04-15 Highly attenuated cytomegalovirus vaccine and production thereof

Publications (1)

Publication Number Publication Date
SE7504221L true SE7504221L (sv) 1975-12-22

Family

ID=23830680

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7504221A SE7504221L (sv) 1974-04-15 1975-04-14 Cellvirusvaccin och forfarande for framstellning av vaccinet.

Country Status (11)

Country Link
US (1) US3959466A (US07122547-20061017-C00273.png)
JP (1) JPS58406B2 (US07122547-20061017-C00273.png)
BE (1) BE827572A (US07122547-20061017-C00273.png)
CA (1) CA1045546A (US07122547-20061017-C00273.png)
CH (1) CH617588A5 (US07122547-20061017-C00273.png)
DE (1) DE2516274C2 (US07122547-20061017-C00273.png)
FR (1) FR2267117B1 (US07122547-20061017-C00273.png)
GB (1) GB1501724A (US07122547-20061017-C00273.png)
NL (1) NL7504480A (US07122547-20061017-C00273.png)
SE (1) SE7504221L (US07122547-20061017-C00273.png)
ZA (1) ZA751949B (US07122547-20061017-C00273.png)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4058598A (en) * 1974-10-18 1977-11-15 Harold Stern Cytomegalovirus attenuation method and vaccine
AU532186B2 (en) * 1978-07-21 1983-09-22 Merck & Co., Inc. Herpes virus vaccine
US6133433A (en) * 1984-07-27 2000-10-17 City Of Hope Method for detection and prevention of human cytomegalovirus infection
US6242567B1 (en) 1984-07-27 2001-06-05 City Of Hope Method for detection and prevention of human cytomegalovirus infection
US5194256A (en) * 1984-08-21 1993-03-16 The Board Of Trustees Of The Leland Sanford Junior University Purified human cytomegalovirus protein
US4689225A (en) * 1984-11-02 1987-08-25 Institut Merieux Vaccine for cytomegalovirus
US5126130A (en) * 1986-11-24 1992-06-30 The Childrens Hospital Incorporated Monoclonal antibodies reactive with specific antigenic sites on human cytomegalovirus glycoprotein a
US5153311A (en) * 1986-11-24 1992-10-06 The Children's Hospital, Incorporated Immunogenic glycoproteins of human cytomegalovirus gCII
US5248768A (en) * 1986-11-24 1993-09-28 The Children's Hospital, Incorporated Immunogenic glycoproteins of human cytomegalovirus
EP0277773A1 (en) * 1987-01-30 1988-08-10 The Board Of Trustees Of The Leland Stanford Junior University Hybrid cytomegalovirus (CMV) and vaccine
US5591439A (en) * 1989-03-24 1997-01-07 The Wistar Institute Of Anatomy And Biology Recombinant cytomegalovirus vaccine
US5552143A (en) * 1989-03-24 1996-09-03 The Wistar Institute Of Anatomy & Biology Recombinant cytomegalovirus vaccine
US5180813A (en) * 1989-03-24 1993-01-19 University Of Iowa Research Foundation Early envelope glycoprotein of human cytomegalovirus (hmcv) and monoclonal antibodies to the glycoproteins
AU2809897A (en) 1996-04-23 1997-11-12 Wistar Institute Of Anatomy And Biology, The Novel human cytomegalovirus dna constructs and uses therefor
US6835383B2 (en) 2000-03-23 2004-12-28 City Of Hope Protein kinase deficient, immunologically active CMVpp65 mutants
EP1178111A1 (en) * 2000-08-03 2002-02-06 Lohmann Animal Health GmbH & Co. KG Vaccination against host cell-associated herpesviruses
US6692954B1 (en) 2000-11-03 2004-02-17 The Scripps Research Institute Generation of human cytomegalovirus yeast artificial chromosome recombinants
US9439960B2 (en) * 2007-10-10 2016-09-13 The Trustees Of Princeton University Cytomegalovirus vaccines and methods of production
WO2021014398A1 (en) 2019-07-23 2021-01-28 University Of Rijeka Faculty Of Medicine Integrated human cytomegalovirus / glioblastoma vaccine

Also Published As

Publication number Publication date
CA1045546A (en) 1979-01-02
AU8002475A (en) 1976-10-14
NL7504480A (nl) 1975-10-17
US3959466A (en) 1976-05-25
JPS58406B2 (ja) 1983-01-06
GB1501724A (en) 1978-02-22
ZA751949B (en) 1976-02-25
CH617588A5 (US07122547-20061017-C00273.png) 1980-06-13
DE2516274A1 (de) 1975-10-23
DE2516274C2 (de) 1986-10-30
JPS5115612A (US07122547-20061017-C00273.png) 1976-02-07
FR2267117A1 (US07122547-20061017-C00273.png) 1975-11-07
FR2267117B1 (US07122547-20061017-C00273.png) 1978-11-24
BE827572A (fr) 1975-10-06

Similar Documents

Publication Publication Date Title
SE7504221L (sv) Cellvirusvaccin och forfarande for framstellning av vaccinet.
BE786240Q (fr) Vaccin contre l'hepatite virale et sa preparation
BE877344A (fr) Acides gras marques par un halogene radioactif, leur utilisation et leur preparation
IL51460A0 (en) Improved live newcastle disease virus vaccines
AU1361976A (en) Hepatitis b antigen and vaccine
PL206218A1 (pl) Sposob wytwarzania oslabionego zaczepu wirusa zakaznego zapalenia zoladka i jelit oraz sposob wytwarzania szczepionki
PT67868A (en) Improved live newcastle disease virus vaccine
GB1292803A (en) Improvements relating to the production of antigens
JPS5244230A (en) Detection of hepatisis antigen and antibody and hepatisis vaccine
FR2303562A1 (fr) Nouvelle preparation d'antigene utilisable comme vaccin
ZA745571B (en) Live influenza virus vaccines and preparation thereof
ZA738918B (en) Live attenuated infectious bovine rhinotracheitis virus vaccines and preparation thereof
BE849897A (fr) Vaccins vivants contre la varicelle et le zona
IT1062543B (it) Vaccino contro il virus della rabbia e metodo per la sua preparazione
IT1043894B (it) Vaccino morto contro rinite atrcfica infettiva dei suini e procedimento per la sua preparazione
BE824372A (fr) Vaccins antigrippaux et procede de leur preparation
GB1538704A (en) Inactivated equine rhinopneumonitis virus vaccine
IT1062135B (it) Composizioni insetticide microbiologiche a base di virus e loro preparazione
BE821175A (fr) Preparation de vaccins a fragments de virus apyretogenes
GB2077590A (en) Highly attenuated varicella virus vaccine and production thereof
DE2962921D1 (en) Feline infectious peritonitis vaccine and process for its preparation
IL46446A (en) Live influenza type b virus vaccines and preparation thereof
AU513734B2 (en) Live influenza virus vaccine
ZA773594B (en) Live influenza virus vaccine and preparation thereof
AU494835B2 (en) Live influenza type b virus vaccines and preparation thereof

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7504221-8

Format of ref document f/p: F